Cardiac Imaging Clinical Trial
Official title:
Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)
| NCT number | NCT03200132 |
| Other study ID # | 16-4-156 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | June 26, 2017 |
| Est. completion date | October 14, 2021 |
| Verified date | April 2022 |
| Source | Maastricht University Medical Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This study evaluates the possibility of Magnetic Resonance Imaging (MRI) based respiratory motion correction of simultaneously acquired cardiac Positron Emission Tomography (PET) images.
| Status | Completed |
| Enrollment | 15 |
| Est. completion date | October 14, 2021 |
| Est. primary completion date | October 14, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - 18F-FDG injection for clinical diagnostic PET/MRI or PET/CT Exclusion Criteria: - Diet-suppressed myocardial uptake of 18F-FDG - General exclusion criteria for MRI (i.e. metallic implants, claustrophobia, pregnancy, etc.) - Not willing to be informed about incidental findings |
| Country | Name | City | State |
|---|---|---|---|
| Netherlands | Maastricht University Hospital | Maastricht | Limburg |
| Lead Sponsor | Collaborator |
|---|---|
| Maastricht University Medical Center |
Netherlands,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Target-to-background ratio (TBR) | 15-20 minutes | ||
| Secondary | Signal-to-noise ratio (SNR) | 15-20 minutes |